Log in

Relevant bibliographies by topics / Cost control Medical care

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Cost control Medical care'

Author: Grafiati

Published: 4 June 2021

Last updated: 14 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Cost control Medical care.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Cost control Medical care"

1

Cooper, Ryan. "Task Assignment and Cost Control in Primary Medical Care." Academy of Management Proceedings 2018, no. 1 (August 2018): 14955. http://dx.doi.org/10.5465/ambpp.2018.203.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Macklin, Ruth. "Cost Containment in Infection Control: Ethical Problems in Rationing Medical Care." Infection Control 6, no. 9 (September 1985): 375–80. http://dx.doi.org/10.1017/s0195941700063359.

Full text

Abstract:

The era of cost containment is upon us. Bureaucrats and regulators, politicians and insurance administrators have begun to devise schemes for reducing the costs of hospital care and medical services in a country justly proud of the quality of its health care. The term “cost containment” has a neutral ring to it, a tone deliberately chosen by policy makers to soften the impact of its effects. The concept has an aura of virtue, conjuring an image of overflowing expenditures that must be put back into the container. But let us recognize the harsh reality that cost containment is simply another term for rationing, a notion that has somewhat unsavory connotations.The need to embark on rationing arises when a crisis of available goods or services is imminent. We are told that too much money is being spent today on health care in the US. Since spending too much on anything is considered wasteful, and since wastefulness is at least an inefficient, if not an unethical way to treat resources, the conclusion seems inescapable that there is a moral imperative to cut costs in the health care sector. To be sure, the goals of eliminating waste and reducing excessive costs should be pursued by hospitals and physicians alike. But let us not hide behind these noble goals and accept uncritically the idea that to increase efficiency in delivering health care, it is necessary to embark on rationing schemes.

APA, Harvard, Vancouver, ISO, and other styles

3

Mohr, John, Michelle Peninger, and Luis Ostrosky-Zeichner. "Infection Control in Intensive Care Units." Journal of Pharmacy Practice 18, no. 2 (April 2005): 84–90. http://dx.doi.org/10.1177/0897190004273569.

Full text

Abstract:

For patients in intensive care units, the development of an infection is associated with an increase in morbidity, mortality, and cost. These infections are largely preventable through the implementation of infection control programs. Infection control programs must focus on 3 general strategies: (1) prevention of health care-associated infections, (2) containment of pathogens that pose a health risk and/or are resistant to routine antibiotics, and (3) development of strategies to limit the emergence of resistant microorganisms through optimal and appropriate antimicrobial utilization. The purpose of this article is to review these 3 general strategies.

APA, Harvard, Vancouver, ISO, and other styles

4

Isenberg, Henry D. "Cost Containment in Infection Control: Is Cost Effective Ordering of Microbiology Tests for Infection Control Possible?" Infection Control 6, no. 10 (October 1985): 425–27. http://dx.doi.org/10.1017/s0195941700063530.

Full text

Abstract:

Prospective payment fever is an all pervasive affliction that will spare no segment of the health care field. The implied rigidity of these regulations will probably not accommodate arguments that infection control efforts are cost-effective in the long run. It shall force all who labor in this field to exercise judicious restraint in the use of institutional resources. Microbiological analyses provide the most factual information lor infection control efforts. However, recent graduates of medical and nursing schools are the victims of the de-emphasis of bread-and-butter microbiology in their curricula. They lack the ability to request only clinically relevant examinations and do not appreciate the implications of microbiological results with respect to the patient and the health of the hospital or the community at large.Cost-effective ordering of microbiological and related patient examinations must, therefore, be based on an educational effort that indoctrinates responsible personnel in the appropriateness of requests based on clinical judgment and laboratory instructions. The DRG-induced change in the basic philosophy of patient care demands that microbiologists must become involved in the clinical use of the information they generate, ie, in the relevance of laboratory data to the care of patients. This interaction must benefit the laboratory scientist, for he or she can now insist that important patient information accompany each specimen.

APA, Harvard, Vancouver, ISO, and other styles

5

Reissman, Debi L. "Cost Containment Strategies in Managed Care Pharmacy Programs." Journal of Pharmacy Practice 5, no. 2 (April 1992): 72–74. http://dx.doi.org/10.1177/089719009200500205.

Full text

Abstract:

Over the past several years prescription drug costs have been escalating at a rate higher than any other single medical expense. For this reason, managed care entities have been focusing much more attention on their prescription drug programs and searching for the magical answer of how to reduce or at least control the spiraling costs. The following article illustrates one author's views and experiences in the management of prescription drug programs. Although the topics discussed in this article are not meant to be all inclusive, several major cost containment strategies, including benefit design, pharmacy network, reimbursement levels, member copayments, formulary systems, physician incentives and others, are highlighted.

APA, Harvard, Vancouver, ISO, and other styles

6

Oesterman, Paul J. "Health Maintenance Organization Drug Education Pharmacists' Influence on Acid Gastric Drug Prescribing and Costs." Journal of Pharmacy Practice 7, no. 4 (August 1994): 155–64. http://dx.doi.org/10.1177/089719009400700404.

Full text

Abstract:

With health care reform came the advent of cost-conscious prescribing. Many measures contributed to this, including formulary control, physician education, and clinical pharmacy. Initial efforts in this regard were limited to the in-patient setting, but as health care reform continued, the significance of cost-effective prescribing in the ambulatory care setting has evolved. This article provides a brief historical look at cost-effective prescribing and how the efforts of a clinical pharmacist have successfully influenced the prescribing patterns for the acid-gastric products, and reduced expenditures in a Northern California health maintenance organization (HMO) medical center.

APA, Harvard, Vancouver, ISO, and other styles

7

Simpson, Kit N., Bryant A. Seamon, Brittany N. Hand, Courtney O. Roldan, David J. Taber, William P. Moran, and Annie N. Simpson. "Effect of frailty on resource use and cost for Medicare patients." Journal of Comparative Effectiveness Research 7, no. 8 (August 2018): 817–25. http://dx.doi.org/10.2217/cer-2018-0029.

Full text

Abstract:

Aim: The effects of frailty and multiple chronic conditions (MCCs) on cost of care are rarely disentangled in archival data studies. We identify the marginal contribution of frailty to medical care cost estimates using Medicare data. Materials & methods: Use of the Faurot frailty score to identify differences in acute medical events and cost of care for patients, controlling for MCCs and medication use. Results: Estimated marginal cost of frailty was US$10,690 after controlling for demographics, comorbid conditions, polypharmacy and use of potentially inappropriate medications. Conclusion: Frailty contributes greatly to cost of care, but while often correlated, is not synonymous with MCCs. Thus, it is important to control separately for frailty in studies that compare medical care use and cost.

APA, Harvard, Vancouver, ISO, and other styles

8

O'Keeffe-Rosetti, M. C., M. C. Hornbrook, P. A. Fishman, D. P. Ritzwoller, E. M. Keast, J. Staab, J. E. Lafata, and R. Salloum. "A Standardized Relative Resource Cost Model for Medical Care: Application to Cancer Control Programs." JNCI Monographs 2013, no. 46 (August 1, 2013): 106–16. http://dx.doi.org/10.1093/jncimonographs/lgt002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Simonet, Daniel. "Medical Practice under Managed Care: Cost-control Mechanisms and Impact on Quality of Service." Public Organization Review 5, no. 2 (June 2005): 157–76. http://dx.doi.org/10.1007/s11115-005-0954-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Hall, Mark A., and Carl E. Schneider. "Can Consumers Control Health-Care Costs?" Forum for Health Economics and Policy 15, no. 3 (September 10, 2012): 23–52. http://dx.doi.org/10.1515/fhep-2012-0008.

Full text

Abstract:

Abstract The ultimate aim of health care policy is good care at good prices. Managed care failed to achieve this goal through influencing providers, so health policy has turned to the only market-based option left: treating patients like consumers. Health insurance and tax policy now pressure patients to spend their own money when they select health plans, providers, and treatments. Expecting patients to choose what they need at the price they want, consumerists believe that market competition will constrain costs while optimizing quality. This classic form of consumerism is today’s health policy watchword. This article evaluates consumerism and the regulatory mechanism of which it is essentially an example – legally mandated disclosure of information. We do so by assessing the crucial assumptions about human nature on which consumerism and mandated disclosure depend. Consumerism operates in a variety of contexts in a variety of ways with a variety of aims. To assess so protean a thing, we ask what a patient’s life would really be like in a consumerist world. The literature abounds in theories about how medical consumers should behave. We look for empirical evidence about how real people actually buy health plans, choose providers, and select treatments. We conclude that consumerism is unlikely to accomplish its goals. Consumerism’s prerequisites are too many and too demanding. First, consumers must have choices that include the coverage, care-takers, and care they want. Second, reliable information about those choices must be available. Third, information must be put before consumers in helpful ways, especially by doctors. Fourth, the information must be complete and comprehensible enough for consumers to use it. Fifth, consumers must understand what they are told. Sixth, consumers must actually analyze the information and do so well enough to make good choices. Our review of the empirical evidence concludes that these prerequisites cannot be met reliably most of the time. At every stage people encounter daunting hurdles. Like so many other dreams of controlling costs and giving patients control, consumerism is doomed to disappoint. This does not mean that consumerist tools should never be used. If all that consumerism accomplished is to raise general cost-consciousness among patients, still, it could make a substantial contribution to the larger cost-control efforts by insurers and the government. Once patients bear responsibility for much day-to-day spending on their health needs, they should be increasingly sensitized to the difficult trade-offs that abound in medical care and might even begin to understand that public and private health insurers have a legitimate interest in controlling medical spending.

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Cost control Medical care"

1

Willis, Susan Beth. "Cost-benefit and cost-effectiveness of case management for a teen pregnancy and parenting program." CSUSB ScholarWorks, 1993. https://scholarworks.lib.csusb.edu/etd-project/630.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Raisch, Dennis William 1952. "ANALYSIS OF ANTIBIOTIC THERAPY IN SELECTED DIAGNOSIS RELATED GROUPS (CLINICAL PHARMACY, PATIENT CARE, LENGTH OF STAY, TREATMENT, CHARGES)." Thesis, The University of Arizona, 1986. http://hdl.handle.net/10150/276371.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Cavanaugh, Teresa M. "Comprehensive Direct Medical Costs Associated with Six Months of Care Status Post Acute Rejection Events in Renal Transplant Recipients: A Single Center Retrospective Matched Case Control Analysis." University of Cincinnati / OhioLINK, 2009. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1243007844.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Carrothers, Leslie C. "Capacity, costs, and control, health care policy in Manitoba from 1948 to 1988." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1999. http://www.collectionscanada.ca/obj/s4/f2/dsk2/ftp03/NQ35041.pdf.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Cheng, Sau-kong. "Diabetic end-stage renal disease (ESRD) : can health care costs be saved through blood pressure control? /." View the Table of Contents & Abstract, 2006. http://sunzi.lib.hku.hk/hkuto/record/B36887638.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Cheng, Sau-kong, and 鄭守崗. "Diabetic end-stage renal disease (ESRD): can health care costs be saved through blood pressure control?" Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2006. http://hub.hku.hk/bib/B39723951.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Mindemark, Mirja. "The Use of Laboratory Analyses in Sweden : Quality and Cost-Effectiveness in Test Utilization." Doctoral thesis, Uppsala universitet, Klinisk kemi, 2010. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-120554.

Full text

Abstract:

Laboratory analyses, essential in screening, diagnosis, treatment, and monitoring of disease, are indispensable in health care, but appropriate utilization is intricate. The overall aim of this thesis was to study the use of laboratory tests in Sweden with the objective to evaluate and optimize test utilization. Considerable inter-county variations in test utilization in primary health care in Sweden were found; variations likely influenced by local traditions and habits of test ordering leading to over- as well as underutilization. Optimized test utilization was demonstrated to convey improved quality and substantial cost savings. It was further established that continuing medical education is a suitable means of optimizing test utilization, and consequently enhancing quality and cost-efficiency, as such education was demonstrated to achieve long-lasting improvements in the test ordering habits of primary health care physicians. Laboratory tests are closely associated with other, greater, health care costs, but their indirect effects on other areas of medicine are rarely evaluated or measured in monetary terms. In an illustrative example of the effects that optimal test utilization may have on associated health care costs it was demonstrated that F-calprotectin, a fecal marker of intestinal inflammation, has the potential to substantially reduce the number of invasive investigations necessary in, and the costs associated with, the diagnosis of Inflammatory Bowel Disease. Information on trends in test utilization is essential to optimal financial management of laboratories. A longitudinal evaluation revealed that test utilization had increased by 70% in 6 years, and even though the selection of tests more than doubled, a very small number of tests represented a stable, and disproportionally large, share of the total number of tests ordered. The study defines trends and thus has potential predictive values. In summary, appropriate utilization of laboratory analyses has both clinical and economical benefits on all levels of health care.

APA, Harvard, Vancouver, ISO, and other styles

8

Eckermann, Simon Economics Australian School of Business UNSW. "Hospital performance including quality: creating economic incentives consistent with evidence-based medicine." Awarded by:University of New South Wales. School of Economics, 2004. http://handle.unsw.edu.au/1959.4/22011.

Full text

Abstract:

This thesis addresses questions of how to incorporate quality of care, represented by disutility-bearing effects such as mortality, morbidity and re-admission, in measuring relative performance of public hospitals. Currently, case-mix funding and performance, measured with costs per case-mix adjusted separation, hold hospitals accountable for costs, but not effects, of care, creating economic incentives for quality of care minimising cost per admission. To allow an appropriate trade-off between the value and cost of quality of care a correspondence is demonstrated between maximising net benefit and minimising costs plus decision makers??? value of disutility events, where effects of care can be represented by disutility events and hospitals face a common comparator. Applying this correspondence to performance measurement, frontier methods specifying disutility events as inputs are illustrated to have distinct advantages over output specifications, allowing estimation of: 1. economic efficiency conditional on the value of avoiding disutility events. 2. technical, scale and congestion sources of net benefit efficiency; 3. best practice peers over potential decision makers??? value of quality; and 4. industry shadow price of avoiding disutility events. The accountability this performance measurement framework provides for effects and cost of quality of care are also illustrated as the basis for moving from case-mix funding towards a funding mechanism based on maximising net benefit. Links to evidence-based medicine in health technology assessment are emphasised in illustrating application of the correspondence to comparison of multiple strategies in the cost-disutility plane, where radial properties as shown to provide distinct advantages over comparison in the cost-effectiveness plane. The identified performance measurement and funding framework allows policy makers to create economic incentives consistent with evidence-based medicine in practice, while avoiding incentives for cream-skimming and cost-shifting. The linear nature of the net benefit correspondence theorem allows simple inclusion of multiple effects of quality, whether expressed as not meeting a standard, functional limitation or disutility directly. In applying the net benefit correspondence theorem to hospitals a clinical activity level is suggested, to allow correspondence conditions to be robustly satisfied in identification of effects with decision analytic methods, adjustment for within DRG risk factors and data linkage to effects beyond separation.

APA, Harvard, Vancouver, ISO, and other styles

9

Richards, Erika Kristin McKeithan. "An analysis of the effect of managed care implementation of prescription drug utilization by Texas Medicaid clients." Access restricted to users with UT Austin EID Full text (PDF) from UMI/Dissertation Abstracts International, 2001. http://wwwlib.umi.com/cr/utexas/fullcit?p3035965.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Baptista, Cleide Maria Caetano. "Avaliação do custo e da eficácia da implantação de um protocolo de prevenção de úlcera por pressão em uma unidade de pronto socorro adulto." Universidade de São Paulo, 2016. http://www.teses.usp.br/teses/disponiveis/7/7140/tde-12052017-123448/.

Full text

Abstract:

Introdução: O atendimento nos Serviços de Emergência não está direcionado para a prevenção de agravos, como a ocorrência de úlceras por pressão (UP), visto que é centrado na manutenção da vida e na estabilização das condições hemodinâmicas dos pacientes. Contudo, há evidências de que poucas horas de permanência em leitos de observação são suficientes para o desenvolvimento de UP tornando fundamental a identificação dos pacientes de risco e a adoção precoce de medidas preventivas. Objetivo: Avaliar os custos e a eficácia da implantação de um protocolo de prevenção de UP na Unidade de Pronto Socorro Adulto (PSA) do Hospital Universitário da Universidade de São Paulo (HU-USP). Método: Trata-se de pesquisa quantitativa, exploratório-descritiva, na modalidade de estudo de caso único. Previamente a implantação do protocolo realizou-se o levantamento dos índices de prevalência e de incidência de UP. Em seguida foi desenvolvido um programa educacional teórico-prático, com ênfase na prevenção de UP, destinado à equipe de enfermagem. Três meses após a implementação do protocolo levantou-se, novamente, os índices de prevalência e de incidência de UP. Para a apuração dos custos diretos foram mapeadas as etapas relativas à aquisição de produtos, acessórios e equipamentos e levantamento dos índices de prevalência e incidência de UP antes e depois da implementação do protocolo. O salário hora/profissional foi multiplicado pelo tempo despendido em cada atividade e o custo unitário dos insumos multiplicado pela quantidade adquirida para a viabilização do protocolo. Resultados: Antes da implantação do protocolo de prevenção de UP, foi obtido o índice de prevalência de 6,67% e de incidência de 3%. Os custos diretos da implantação do protocolo totalizaram R$ 31.870,00 (100%) sendo R$ 11.650,93 (36,56%) relativos às atividades de implementação; R$ 10.102,90 (31,70%) referentes à MOD das enfermeiras que levantaram os índices de prevalência e incidência de UP antes da implantação; R$ 7.079,67 (22,21%) referentes à MOD das enfermeiras que levantaram os índices de prevalência e incidência de UP depois da implementação e R$ 3.036,50 (9,53%) para a aquisição de produtos, acessórios e equipamentos. Após a implementação evidenciou-se a diminuição nos índices de prevalência e de incidência para 0% e 1,38%, respectivamente. Conclusão: O investimento na capacitação teórico-prática dos profissionais de enfermagem e a aquisição de produtos, acessórios e equipamentos, necessários para viabilizar a exequibilidade do protocolo de prevenção, são fatores indissociáveis para o alcance de um resultado eficaz e, consequentemente, melhoria contínua da qualidade da assistência.
Introduction: The care in Emergency Services is not directed at the prevention of diseases, as the occurrence of pressure ulcers (PU), since its focus is based on the maintenance of life and stabilization of hemodynamic conditions of patients. However, there is evidence that a few hours spent in observation beds are sufficient for the development of PU, being important to identify risk patients and the early adoption of preventive measures. Objective: To evaluate the cost and effectiveness for the implementation of a PU prevention protocol in Adult Emergency Services (AES) at the University Hospital of the Universidade de São Paulo (UH-USP). Method: This is quantitative, exploratory and descriptive study, with a single case study design. Previously to the protocol implementation, a survey on the prevalence and incidence of PU was carried out. Next, theoretical and practical educational program, with emphasis on prevention of PU, was developed for the nursing staff. Three months after the protocol implementation, again, the prevalence and incidence of PU was assessed. For the calculation of direct costs, the stages related to the acquisition of products, accessories and equipment were mapped, and also a survey on the prevalence and incidence of PU before and after protocol implementation was performed. The hourly wage / professional was multiplied by the time spent on each activity and the unit cost of inputs multiplied by the amount acquired for the viability of the protocol. Results: Before the implementation of PU prevention protocol, the prevalence rate of 6.67% and incidence of 3% were obtained. The direct costs for implementing the protocol amounted to R $ 31.870.00 (100%) being R $ 11.650,93 (36.56%) regarding the implementation of activities; R $ 10.102,90 (31.70%) for the MOD of nurses who raised the prevalence and incidence of UP rate before implementation; R $ 7.079,67 (22.21%) for the MOD of nurses who raised the prevalence and incidence of UP rates after implantation and R $ 3.036,50 (9.53%) for the acquisition of products, accessories and equipment. After implantation it was observed a decrease in prevalence and incidence rates to 0% and 1.38% respectively. Conclusion: Investment in theory and practice training for nurses and the acquisition of products, accessories and equipment necessary to enable the feasibility of the prevention protocol, are factors inextricably linked to achieving an effectively outcome and consequently improving continuous quality of care.

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Cost control Medical care"

1

Capuzzi, Cecelia. Cost control and managed health care. Portland, Or: Office of Health Policy, Dept. of Human Resouces, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Health Care Cost Containment Seminar (4th 1984 Miami, Fla.). Health care cost containment, 1984. Brookfield, Wis: International Foundation of Employee Benefit Plans, 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Dobson, Allen. Trends in health care cost management. Washington, D.C: NEA, Professional and Organizational Development/Research Division, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Commission, Nevada Legislature Legislative. Restraining costs of medical care in Nevada. [Carson City, Nev.]: Legislative Commission of the Legislative Counsel Bureau, State of Nevada, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Office, General Accounting. Health care: Unsustainable trends necessitate comprehensive and fundamental reforms to control spending and improve value. Washington, D.C: The Office, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Seminar on Health Cost Containment (1985 Washington, D.C.). Health care cost containment: A Seminar on Health Cost Containment, March 14-15, 1985, Washington, D.C. Lexington, Ky: Council of State Governments, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Cannon, Michael F. Medicaid's Unseen Costs. Washington, D.C: Cato Institute, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

McCall, Nelda. Managed Medicaid cost savings: The Arizona experience. San Francisco, CA: Laguna Research Associates, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Commission, Massachusetts Rate Setting. Health care costs in Massachusetts. [Boston, Mass.] (Two Boylston St., Boston 02116): Massachusetts Rate Setting Commission, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Schwartz, William B. Health care costs: The social tradeoffs. Washington, D.C: Brookings Institution, 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Cost control Medical care"

1

Viskoper, J. R., S. Oren, L. Bregman, J. Mishal, and G. M. Ginsberg. "The Ashkelon Hypertension Detection and Control Program Medical and Cost Implications." In Costs and Benefits in Health Care and Prevention, 72–78. Berlin, Heidelberg: Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-75781-5_9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Monfardini, S., K. Brunner, D. Crowther, S. Eckhardt, D. Olive, S. Tanneberger, A. Veronesi, J. M. A. Whitehouse, and R. Wittes. "Pain Control and Terminal Care." In Manual of Adult and Paediatric Medical Oncology, 108–15. Berlin, Heidelberg: Springer Berlin Heidelberg, 1987. http://dx.doi.org/10.1007/978-3-642-82489-0_11.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Covato, Angela. "Vignette: Taking Control of Thalassemia." In Communications in Medical and Care Compunetics, 67–70. Berlin, Heidelberg: Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-642-38643-5_7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Wiramus, Sandrine, David Delahaye, Sébastien Parratte, Jacques Albanese, and Jean-Noël Argenson. "Cost-Effectiveness of the Various Modalities for Pain Control." In Perioperative Medical Management for Total Joint Arthroplasty, 131–39. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-07203-6_12.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Dutta, Meghamala, Sourav Dutta, Swati Sikdar, Deepneha Dutta, Gayatri Sharma, and Ashika Sharma. "Reliable, Real-Time, Low Cost Cardiac Health Monitoring System for Affordable Patient Care." In Advancements of Medical Electronics, 281–89. New Delhi: Springer India, 2015. http://dx.doi.org/10.1007/978-81-322-2256-9_26.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Crane, D. Russell, and Jacob Christenson. "A Summary Report of Cost-Effectiveness: Recognizing the Value of Family Therapy in Health Care." In Medical Family Therapy, 419–36. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-03482-9_22.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Birch, Stephen, and Amiram Gafni. "Cost-Effectiveness and Cost Utility Analyses: Methods for the Non-Economic Evaluation of Health Care Programmes and How We Can Do Better." In Management of Medical Technology, 51–67. Boston, MA: Springer US, 1996. http://dx.doi.org/10.1007/978-1-4613-1415-8_4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Brock, Stan, and Amanda Wilson. "Remote Area Medical®: Pioneers of No-Cost Health Care." In Healthcare Disparities at the Crossroads with Healthcare Reform, 413–20. Boston, MA: Springer US, 2011. http://dx.doi.org/10.1007/978-1-4419-7136-4_22.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Senagore, Anthony J. "Cost of Medical Care: Whose Money Are We Talking About?" In Pelvic Cancer Surgery, 647–52. London: Springer London, 2015. http://dx.doi.org/10.1007/978-1-4471-4258-4_58.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Alexandre, Pierre Kébreau, M. Christopher Roebuck, Michael T. French, Dale D. Chitwood, and Clyde B. McCoy. "Problem Drinking, Health Services Utilization, and the Cost of Medical Care." In Alcoholism, 285–98. Boston, MA: Springer US, 2002. http://dx.doi.org/10.1007/978-0-306-47193-3_16.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Cost control Medical care"

1

Ortega-Palacios, R., J. L. Bueno-Lamas, J. G. Vazquez-Lopez, J. C. Salgado-Ramirez, I. Ortiz-Hernandez, A. Vera, and L. Leija. "Low-cost upper limb prosthesis, based on opensource projects with voice-myoelectric hybrid control." In 2018 Global Medical Engineering Physics Exchanges/Pan American Health Care Exchanges (GMEPE/PAHCE). IEEE, 2018. http://dx.doi.org/10.1109/gmepe-pahce.2018.8400727.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Gruber, W. H. "Cost Shifting In The Current Medical Environment." In Health Care Technology Policy I: The Role of Technology in the Cost of Health Care. IEEE, 1994. http://dx.doi.org/10.1109/hctp.1994.721299.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Langlotz, Curtis P., Bridget Cleff, Orit Even-Shoshan, Mary T. Bozzo, Regina O. Redfern, Inna Brikman, Sridhar B. Seshadri, Steven C. Horii, and Harold L. Kundel. "Incremental cost of PACS in a medical intensive care unit." In Medical Imaging 1995, edited by R. Gilbert Jost and Samuel J. Dwyer III. SPIE, 1995. http://dx.doi.org/10.1117/12.208788.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Langlotz, Curtis P., Harold L. Kundel, Inna Brikman, Hugh M. Pratt, Regina O. Redfern, Steven C. Horii, and J. Sanford Schwartz. "Effect of PACS/CR on cost of care and length of stay in a medical intensive care unit." In Medical Imaging 1996, edited by R. Gilbert Jost and Samuel J. Dwyer III. SPIE, 1996. http://dx.doi.org/10.1117/12.239258.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Samuel, Liji. "TRANSFORMING THE HEALTHCARE SYSTEM: THE PUBLIC-PRIVATE HEALTHCARE DICHOTOMY IN INDIA IN THE ERA OF DIGITAL HEALTH." In International Conference on Public Health. The International Institute of Knowledge Management, 2021. http://dx.doi.org/10.17501/24246735.2020.6103.

Full text

Abstract:

Digital health initiatives have become popular in all jurisdictions across the globe. The digital health move, though it is envisioned as a cost-effective way to ensure the availability of health care services especially for the people who live in rural areas, its success depends on the response of the health care system and the state control and regulation. India lacks a comprehensive statesponsored or state-regulated health care system and more than 70 percent of people utilise the private sector medical services. In this backdrop, the implementation of the National Digital Health Mission (NDHM), announced by the Government of India very recently, will be critical. Thus, this research paper strives to bring out the public-private disjunction in the availability and utilisation of public and private health care facilities, issues of health care financing and legal regulation of clinical establishments in the public and private sector. This study uses the doctrinal method and analyses the Five-Year Plans, National Sample Survey Reports, National Health Profile, National Health Accounts Estimates for India and other Government Reports and independent studies to detail the public-private dichotomy. However, this study finds limitations in presenting the current position of private health care service providers due to the unavailability of updated authoritative government reports/ studies/ surveys. On reviewing the currents trends in the public and private health care sector, the study finds that the private sector has surpassed the public sector in all means, including health provisioning, utilisation, and financing. The NDHM is a laudable initiative to ensure affordable health care to millions of people in India. However, any move to implement it, leaving the fundamental issue of deep-rooted public-private dichotomy existing in the healthcare sector will be detrimental. It will result in a digital divide in the public and private healthcare sector and gross violation of patients’ rights and mismanagement of health information. Keywords: digital health, National Digital Health Mission, private healthcare sector, utilisation of healthcare service

APA, Harvard, Vancouver, ISO, and other styles

6

Fitch, J. Patrick. "Testing a potential national strategy for cost-effective medical technology." In Health Care Technology Policy II: The Role of Technology in the Cost of Health Care: Providing the Solutions, edited by Warren S. Grundfest. SPIE, 1995. http://dx.doi.org/10.1117/12.225321.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Arif, Maria, Megha Kuliha, and Sunita Varma. "Blockchain Architecture to Meet Challenges in Management of Electronic Health Records in IoT based Healthcare Systems." In 2nd International Conference on Machine Learning, IOT and Blockchain (MLIOB 2021). Academy and Industry Research Collaboration Center (AIRCC), 2021. http://dx.doi.org/10.5121/csit.2021.111204.

Full text

Abstract:

Secure, immutable and transparent feature of blockchain has led researchers to find ways to harness its potential in sectors other than financial services. Blockchain is emerging as a popular tool to help solve some of the healthcare industry's age-old problems that have resulted in delayed treatments, inaccessible health records in emergency, wasteful spending and higher costs for doctors, health care providers, insurers and patients. Applying blockchain in healthcare brings a new challenge of integrating blockchain with Internet of Things (IoT) networks as sensor based medical and wearable devices are now used to gather information about the health of a patient and provide it to medical applications using wireless networking. This paper proposes an architecture that would provide a decentralized, secure, immutable, transparent, scalable and traceable system for management and access control of electronic health records (EHRs) through the use of consortium blockchain, smart contracts, proof-ofauthentication (PoAh) consensus protocol and decentralized cloud.

APA, Harvard, Vancouver, ISO, and other styles

8

Hebert, Kolby V., Rachel S. Keen, Derek R. King, and Sally F. Shady. "Gait-Monitoring Wearable Technology for Transtibial Prosthetics." In ASME 2016 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2016. http://dx.doi.org/10.1115/imece2016-66226.

Full text

Abstract:

Approximately 40,000 transtibial amputations occur each year in the United States. Current lower leg prosthetic options range from passive artificial limbs to computerized electronic models [1]. Because of insurance limitations, most patients use less sophisticated prosthetics. The average cost of lower leg prosthetics and corresponding medical care for single-leg veterans is at least $1.4 million due to increased rehabilitation times [1]. Gait training methods for transtibial amputees include extended rehabilitation processes lasting up to 9 months. These exercises provide no empirical data to analyze patient gait progress. The device design is a wearable technology that acquires gait information that is evidentiary for physicians when deciding to continue or dismiss further rehabilitation and follow up medical appointments. The technology includes a gyroscope, accelerometer, microprocessor, and electronic components housed in a 3D printed casing that is attachable to any prosthetic, or a biological leg. Pressure sensors are embedded into a sock-like foot covering that is used in tandem with the other electronics. Gait data collection was validated by comparing gait parameter values with literature values. A series of control tests on non-amputees was conducted in order to gather standard data and develop consistent testing practices for the prototype design. These findings are used as a reference when evaluating amputee gait data against non-amputee gait data. As the microprocessor collects data, information is stored onto a memory card used to relay data to the developed program for data analysis. Data analysis is supported by a graphical user interface via LabView which provides valuable gait data to physicians and physical therapists. Gait data analysis is expected to result in asymmetrical patterns for below-the-knee amputees compared to non-amputees as well as abnormal pressure loads throughout the foot [1].

APA, Harvard, Vancouver, ISO, and other styles

9

Kumar, M. Rajendra, Manjunatha Mahadevappa, and Dharitri Goswami. "Low cost point of care estimation of Hemoglobin levels." In 2014 International Conference on Medical Imaging, m-Health and Emerging Communication Systems (MedCom). IEEE, 2014. http://dx.doi.org/10.1109/medcom.2014.7006007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Fitzmaurice, J. M. "Developing and sharing medical effectiveness information." In Health Care Technology Policy II: The Role of Technology in the Cost of Health Care: Providing the Solutions, edited by Warren S. Grundfest. SPIE, 1995. http://dx.doi.org/10.1117/12.225302.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Cost control Medical care"

1

Candrilli, Sean D., and Samantha Kurosky. The Response to and Cost of Meningococcal Disease Outbreaks in University Campus Settings: A Case Study in Oregon, United States. RTI Press, October 2019. http://dx.doi.org/10.3768/rtipress.2019.rr.0034.1910.

Full text

Abstract:

Invasive meningococcal disease (IMD) is a contagious bacterial infection that can occur sporadically in healthy individuals. Symptoms are typically similar to other common diseases, which can result in delayed diagnosis and treatment until patients are critically ill. In the United States, IMD outbreaks are rare and unpredictable. During an outbreak, rapidly marshalling the personnel and monetary resources to respond is paramount to controlling disease spread. If a community lacks necessary resources for a quick and efficient outbreak response, the resulting economic cost can be overwhelming. We developed a conceptual framework of activities implemented by universities, health departments, and community partners when responding to university-based IMD outbreaks. Next, cost data collected from public sources and interviews were applied to the conceptual framework to estimate the economic cost, both direct and indirect, of a university-based IMD outbreak. We used data from two recent university outbreaks in Oregon as case studies. Findings indicate a university-based IMD outbreak response relies on coordination between health care providers/insurers, university staff, media, government, and volunteers, along with many other community members. The estimated economic cost was $12.3 million, inclusive of the cost of vaccines ($7.35 million). Much of the total cost was attributable to wrongful death and indirect costs (e.g., productivity loss resulting from death). Understanding the breadth of activities and the economic cost of such a response may inform budgeting for future outbreak preparedness and development of alternative strategies to prevent and/or control IMD.

APA, Harvard, Vancouver, ISO, and other styles

2

Cicala, Steve, Ethan M. J. Lieber, and Victoria Marone. Cost of Service Regulation in U.S. Health Care: Minimum Medical Loss Ratios. Cambridge, MA: National Bureau of Economic Research, April 2017. http://dx.doi.org/10.3386/w23353.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Barro, Jason, Robert Huckman, and Daniel Kessler. The Effects of Cardiac Specialty Hospitals on the Cost and Quality of Medical Care. Cambridge, MA: National Bureau of Economic Research, October 2005. http://dx.doi.org/10.3386/w11707.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Kessler, Daniel, and Jeffrey Geppert. The Effects of Competition on Variation in the Quality and Cost of Medical Care. Cambridge, MA: National Bureau of Economic Research, March 2005. http://dx.doi.org/10.3386/w11226.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Rheney, Chris. The Rising Cost of Civilian Trauma Care at Brooke Army Medical Center: Strategies and Solutions. Fort Belvoir, VA: Defense Technical Information Center, June 2003. http://dx.doi.org/10.21236/ada421273.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Burgess, Scott A. Active Duty Access to Specialty Care Within the Great Plains Regional Medical Command: A Cost Benefit Analysis. Fort Belvoir, VA: Defense Technical Information Center, June 1998. http://dx.doi.org/10.21236/ada372404.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Gindi, Renee. Health, United States, 2019. Centers for Disease Control and Prevention (U.S.), 2021. http://dx.doi.org/10.15620/cdc:100685.

Full text

Abstract:

Health, United States, 2019 is the 43rd report on the health status of the nation and is submitted by the Secretary of the Department of Health and Human Services to the President and the Congress of the United States in compliance with Section 308 of the Public Health Service Act. This report was compiled by the National Center for Health Statistics (NCHS) of the Centers for Disease Control and Prevention (CDC). The Health, United States series presents an annual overview of national trends in key health indicators. The 2019 report presents trends and current information on selected measures of morbidity, mortality, health care utilization and access, health risk factors, prevention, health insurance, and personal health care expenditures in a 20-figure chartbook. The Health, United States, 2019 Chartbook is supplemented by several other products including Trend Tables, an At-a-Glance table, and Appendixes available for download on the Health, United States website at: https://www.cdc.gov/nchs/hus/ index.htm. The Health, United States, 2019 Chartbook contains 20 figures and 20 tables on health and health care in the United States. Examining trends in health informs the development, implementation, and evaluation of health policies and programs. The first section (Figures 1–13) focuses on health status and determinants: life expectancy, infant mortality, selected causes of death, overdose deaths, suicide, maternal mortality, teen births, preterm births, use of tobacco products, asthma, hypertension, heart disease and cancer, and functional limitations. The second section (Figures 14–15) presents trends in health care utilization: use of mammography and colorectal tests and unmet medical needs. The third section (Figures 16–17) focuses on health care resources: availability of physicians and dentists. The fourth section (Figures 18–20) describes trends in personal health care expenditures, health insurance coverage, and supplemental insurance coverage among Medicare beneficiaries. The Highlights section summarizes major findings from the Chartbook. Suggested citation: National Center for Health Statistics. Health, United States, 2019. Hyattsville, MD. 2021.

APA, Harvard, Vancouver, ISO, and other styles

8

Yang, Xinwei, Huan Tu, and Xiali Xue. The improvement of the Lower Limb exoskeletons on the gait of patients with spinal cord injury: A protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, August 2021. http://dx.doi.org/10.37766/inplasy2021.8.0095.

Full text

Abstract:

Review question / Objective: The purpose of this systematic review and meta-analysis was to determine the efficacy of lower extremity exoskeletons in improving gait function in patients with spinal cord injury, compared with placebo or other treatments. Condition being studied: Spinal Cord Injury (SCI) is a severely disabling disease. In the process of SCI rehabilitation treatment, improving patients' walking ability, improving their self-care ability, and enhancing patients' self-esteem is an important aspect of their return to society, which can also reduce the cost of patients, so the rehabilitation of lower limbs is very important. The lower extremity exoskeleton robot is a bionic robot designed according to the principles of robotics, mechanism, bionics, control theory, communication technology, and information processing technology, which can be worn on the lower extremity of the human body and complete specific tasks under the user's control. The purpose of this study was to evaluate the effect of the lower extremity exoskeleton on the improvement of gait function in patients with spinal cord injury.

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!